Related Experiment Video

Updated: Dec 13, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.1K

Hypercoagulable State in COVID-19: A Case Series of Three Patients

Gideon Logan1, Larissa Dub1, Emily Drone2

  • 1Emergency Medicine, University of Central Florida College of Medicine, Orlando, USA.

Cureus
|August 6, 2020
PubMed

Insights

The COVID-19 pandemic, caused by SARS-CoV-2, has led to serious illness globally. This study highlights that thromboembolic complications can occur in patients with COVID-19.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Cardiology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in significant global morbidity and mortality.
  • Hallmark symptoms include fever, cough, and shortness of breath, but other complications are emerging.
  • Thromboembolic events represent a serious concern in COVID-19 patients.

Observation:

  • Three emergency department patients tested positive for COVID-19.
  • These patients presented with or developed thromboembolic complications.
  • This case series underscores a critical, less-recognized aspect of the disease.

Findings:

  • COVID-19 is associated with an increased risk of thromboembolic complications.
  • Early identification and management of these complications are crucial.
  • The spectrum of COVID-19 manifestations includes vascular events.

Implications:

  • Healthcare providers should be vigilant for thromboembolic events in COVID-19 patients.
  • Further research is needed to understand the mechanisms and optimal treatment strategies.
  • Recognizing these complications can improve patient outcomes and inform clinical guidelines.

Keywords:
acute pulmonary embolismcovid-19dvthypercoagulablenovel coronavirusprothromboticsars-cov-2venous thromboembolsim

Related Concept Videos

Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.0K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.2K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
180
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
180
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
154
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
378